THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

PDT Partners, LLC's Holding History (CIK: 0001564702)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 92,557 Value ($000) $1,732 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 109,709 Value ($000) $1,602 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 120,327 Value ($000) $1,327 Avg Close $9.72 Range $7.90 - $11.82
Q1 2025
Shares 88,577 Value ($000) $791 Avg Close $9.31 Range $8.35 - $10.90
Q4 2024
Shares 37,676 Value ($000) $355 Avg Close $9.10 Range $7.88 - $10.26
Q3 2024
Shares 87,177 Value ($000) $703 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 66,439 Value ($000) $563 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 66,439 Value ($000) $596 Avg Close $9.27 Range $8.21 - $11.71
Q4 2023
Shares 32,423 Value ($000) $364 Avg Close $10.06 Range $8.52 - $11.57
Q3 2023
Shares 81,458 Value ($000) $703 Avg Close $9.65 Range $8.25 - $10.59
Q2 2023
Shares 82,158 Value ($000) $850 Avg Close $11.04 Range $9.98 - $12.03
Q1 2023
Shares 82,361 Value ($000) $894 Avg Close $10.57 Range $9.25 - $11.52
Q4 2022
Shares 82,322 Value ($000) $924 Avg Close $10.51 Range $9.56 - $11.83
Q3 2022
Shares 81,658 Value ($000) $828 Avg Close $9.37 Range $7.53 - $11.00
Q2 2022
Shares 156,131 Value ($000) $1,415 Avg Close $9.21 Range $8.15 - $10.52
Q1 2022
Shares 192,701 Value ($000) $1,842 Avg Close $9.80 Range $7.71 - $13.17
Q4 2021
Shares 111,379 Value ($000) $1,231 Avg Close $8.72 Range $7.30 - $11.24
Q4 2020
Shares 54,522 Value ($000) $969 Avg Close $17.95 Range $14.48 - $20.53
Q3 2020
Shares 66,061 Value ($000) $977 Avg Close $18.73 Range $14.62 - $22.82
Q2 2020
Shares 24,614 Value ($000) $517 Avg Close $25.69 Range $20.17 - $31.35
Q3 2015
Shares 17,683 Value ($000) $194 Avg Close $12.73 Range $10.69 - $15.00
Q2 2015
Shares 42,927 Value ($000) $559 Avg Close $15.51 Range $12.52 - $18.92
Q1 2015
Shares 16,393 Value ($000) $284 Avg Close $18.33 Range $14.59 - $22.00